Becton, Dickinson and Company Stock
Stocks
BDX
US0758871091
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
04:00:02 2026-11-13 pm EST
|
5-day change | 1st Jan Change | ||
| 218.03 USD | +1.08% |
|
+2.90% | +12.35% |
| Nov. 10 | Waters Says US FDA Clearance Obtained for Leukemia, Lymphoma Clinical Tests | MT |
| Nov. 06 | TD Cowen Adjusts Becton, Dickinson Price Target to $214 From $182 | MT |
| Market Cap | 59.39B 53.82B 49.78B 44.91B 84.64B 5,600B 87.62B 598B 237B 2,991B 223B 218B 9,495B | P/E 2026 |
43.8x | P/E 2027 * | 29.6x |
|---|---|---|---|---|---|
| Enterprise Value | 75.27B 68.21B 63.09B 56.93B 107B 7,097B 111B 758B 301B 3,791B 282B 276B 12,035B | EV / Sales 2026 |
2.51x | EV / Sales 2027 * | 3.74x |
| Free-Float |
73.18% | Yield 2026 * |
1.92% | Yield 2027 * | 1.92% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BDX | Delayed | |
CBOE
| BDX | Real-time | |
|
Tradegate
| BOX | Real-time | |
|
Boerse Muenchen
| BOX | Real-time | |
|
London S.E.
| 0R19 | Delayed | |
|
Börse Stuttgart
| BOX | Delayed | |
|
Xetra
| BOX | End-of-day quote | |
|
Mexican S.E.
| BDX * | End-of-day quote | |
|
Deutsche Boerse AG
| BOX | Delayed | |
|
Wiener Boerse
| BDX | End-of-day quote | |
|
Borsa Italiana
| 1BDX | End-of-day quote | |
|
Swiss Exchange
| BDX | Delayed | |
|
Swiss Exchange
| BDX | Delayed |
Last Transcript: Becton, Dickinson and Company
| 1 day | +1.08% | ||
| 1 week | +2.90% | ||
| Current month | +10.18% | ||
| 1 month | +16.36% | ||
| 3 months | +19.82% | ||
| 6 months | +51.22% | ||
| Current year | +12.35% |
| 1 week | 209 |  | 219.78 |
| 1 month | 189.49 | | 219.78 |
| Current year | 140.11 | | 219.78 |
| 1 year | 140.11 | | 219.78 |
| 3 years | 140.11 | | 251.98 |
| 5 years | 140.11 | | 287.32 |
| 10 years | 140.11 | | 287.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 53 | 2020-01-27 |
Vitor Roque
DFI | Director of Finance/CFO | 44 | 2025-12-04 |
Ronald Silverman
CTO | Chief Tech/Sci/R&D Officer | 56 | 2023-12-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 75 | 2002-09-23 |
| Director/Board Member | 71 | 2010-07-25 | |
Thomas Polen
CHM | Chairman | 53 | 2021-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/26/26 | Sell | Executive/Senior Manager | -76 | 0.0000% | ||
| 9/28/26 | Sell | Executive/Senior Manager | -76 | 0.0000% | ||
| 9/2/26 | Tax | Chief Financial Officer | -190 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.08% | +2.90% | +12.95% | -7.56% | 59.39B | |
| +1.18% | -1.28% | -16.05% | +13.29% | 188B | |
| +1.85% | +1.04% | +6.99% | +42.70% | 126B | |
| -0.88% | -4.98% | -17.08% | +9.86% | 118B | |
| +1.36% | -5.91% | -43.00% | +3.16% | 92.48B | |
| +2.96% | +7.64% | -1.76% | +80.54% | 68.51B | |
| +0.89% | +4.17% | +0.39% | +62.87% | 55.48B | |
| -0.68% | +6.83% | -1.64% | +55.26% | 49.62B | |
| -1.28% | -0.43% | - | - | 34.68B | |
| +1.79% | +0.10% | -2.42% | -6.49% | 35.17B | |
| Average | +0.55% | +0.53% | -6.85% | +28.18% | 83B | |
| Weighted average by Cap. | +0.52% | -0.38% | -9.62% | +25.74% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 19.29B 17.48B 16.17B 14.59B 27.49B 1,819B 28.46B 194B 77.02B 972B 72.39B 70.86B 3,084B | 19.8B 17.94B 16.59B 14.97B 28.21B 1,867B 29.21B 199B 79.04B 997B 74.29B 72.71B 3,165B |
| Net income | 1.41B 1.27B 1.18B 1.06B 2B 133B 2.07B 14.16B 5.61B 70.83B 5.28B 5.17B 225B | 2.01B 1.82B 1.69B 1.52B 2.87B 190B 2.97B 20.24B 8.03B 101B 7.54B 7.38B 321B |
| Net Debt | 15.88B 14.39B 13.31B 12.01B 22.64B 1,498B 23.44B 160B 63.42B 800B 59.61B 58.35B 2,540B | 14.63B 13.26B 12.26B 11.06B 20.85B 1,379B 21.58B 147B 58.4B 737B 54.89B 53.73B 2,339B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | $218.03 | +1.08% | 1,879,909 |
| 26-11-12 | $215.71 | +0.55% | 1,762,438 |
| 26-11-11 | $214.52 | +0.90% | 1,637,589 |
| 26-11-10 | $212.61 | -1.23% | 1,790,253 |
| 26-11-09 | $215.25 | +1.59% | 2,039,094 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BDX Stock
Select your edition
All financial news and data tailored to specific country editions
